141 related articles for article (PubMed ID: 37681751)
1. Necroptosis-related regulatory pattern and scoring system for predicting therapeutic efficacy and prognosis in ovarian cancer.
Lai H; Guo Y; Wu L; Yusufu A; Zhong Q; Liao Z; Ma J; Shi W; Yang G; Chen S
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1893. PubMed ID: 37681751
[TBL] [Abstract][Full Text] [Related]
2. Two novel prognostic models for ovarian cancer respectively based on ferroptosis and necroptosis.
Li Y; Gong X; Hu T; Chen Y
BMC Cancer; 2022 Jan; 22(1):74. PubMed ID: 35039008
[TBL] [Abstract][Full Text] [Related]
3. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer.
Wang Z; Chen G; Dai F; Liu S; Hu W; Cheng Y
Front Immunol; 2022; 13():894718. PubMed ID: 35812403
[TBL] [Abstract][Full Text] [Related]
4. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
[TBL] [Abstract][Full Text] [Related]
5. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
Huo J; Xie W; Fan X; Sun P
Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W
Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900
[TBL] [Abstract][Full Text] [Related]
8. Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer.
Luo W; Xiang W; Gan L; Che J; Li J; Wang Y; Han L; Gu R; Ye L; Wang R; Zhang X; Xu Y; Dai W; Mo S; Li Q; Cai G
J Transl Med; 2022 May; 20(1):235. PubMed ID: 35590418
[TBL] [Abstract][Full Text] [Related]
9. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
10. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
Zheng C; Guo H; Mo Y; Liu G
Recent Pat Anticancer Drug Discov; 2023 Aug; ():. PubMed ID: 37653627
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
[TBL] [Abstract][Full Text] [Related]
12. A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer.
Wang Z; Huang Z; Cao X; Zhang F; Cai J; Tang P; Yang C; Li S; Yu D; Yan Y; Shen B
BMC Urol; 2023 Jan; 23(1):10. PubMed ID: 36709279
[TBL] [Abstract][Full Text] [Related]
13. MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma.
Zhong B; Wang Y; Liao Y; Liang J; Wang K; Zhou D; Zhao Y; Jiang N
Apoptosis; 2023 Jun; 28(5-6):892-911. PubMed ID: 37000317
[TBL] [Abstract][Full Text] [Related]
14. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer.
Zhang ZC; Guo JN; Zhang N; Wang ZQ; Lou G; Cui BB; Yang C
Front Immunol; 2021; 12():763791. PubMed ID: 34880862
[TBL] [Abstract][Full Text] [Related]
16. A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors.
Li H; Lv Z; Liu M
Medicine (Baltimore); 2023 Oct; 102(41):e35196. PubMed ID: 37832111
[TBL] [Abstract][Full Text] [Related]
17. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
18. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
[TBL] [Abstract][Full Text] [Related]
19. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.
He WP; Chen YY; Wu LX; Guo YY; You ZS; Yang GF
Front Immunol; 2022; 13():1018544. PubMed ID: 36466815
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
